CERO THERAPEUTICS HOLDINGS, INC. - CERO
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parallel Advisors, LLC | History | Reduced | 121,000 | 615 | 0.01% | 0.04% | 1 | -99,000 | -45.0% | Q3 2025 | Nov 13, 2025 |
| ARCH Venture Management, LLC | History | No change | 22,389 | 113 | 0.02% | 0.07% | 2 | 0 | 0.0% | Q3 2025 | Nov 14, 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | History | New | 10,244 | 52 | 0.0% | — | 3 | +10,244 | New | Q3 2025 | Nov 14, 2025 |
| Tower Research Capital LLC (TRC) | History | Added to | 1,299 | 6 | 0.0% | 0.0% | 4 | +615 | 89.91% | Q3 2025 | Nov 14, 2025 |
| FNY Investment Advisers, LLC | History | No change | 1,050 | 5 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q3 2025 | Dec 15, 2025 |
| CITIGROUP INC | History | New | 968 | 4 | 0.0% | — | 6 | +968 | New | Q3 2025 | Nov 10, 2025 |
| UBS Group AG | History | Reduced | 6 | 0 | — | 0.0% | — | -2,619 | -99.77% | Q3 2025 | Nov 13, 2025 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 3 | 0 | — | — | — | +1 | 50.0% | Q3 2025 | Feb 03, 2026 |
| JONES FINANCIAL COMPANIES LLLP | History | No change | 3 | 0 | — | — | — | 0 | 0.0% | Q3 2025 | Nov 04, 2025 |
| SBI Securities Co., Ltd. | History | No change | 18 | 0 | — | — | — | 0 | 0.0% | Q3 2025 | Nov 05, 2025 |